National Institute of Neurological Disorders and Stroke; Notice of Meetings, 1729-1730 [05-384]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 6 / Monday, January 10, 2005 / Notices
Dated: January 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–390 Filed 1–7–05:8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Review of Conference Meeting (R13)
Applications.
Date: February 25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Shelley S. Sehnert, PhD,
Scientific Review Administrator, Review
Branch, NIH/NHLBI, 6701 Rockledge Drive,
Room 7206, Bethesda, MD 20892–7492. 301–
435–0303.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
CV Risks in American Indians and Alaskan
Natives.
Date: March 17, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel & Executive
Meeting Center Rockville, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: William J. Johnson, PhD,
Review Branch, Division of Extramural
Affairs, National Heart, Lung and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7184, MSC 7924,
Bethesda, MD 20892. 301–435–0275.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Review of Training Grants (K18s, K23s, K24s,
and K25s).
Date: March 17–18, 2005.
VerDate jul<14>2003
18:09 Jan 07, 2005
Jkt 205001
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Roy L. White, PhD, Review
Branch, Division of Extramural Affairs,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6701 Rockledge
Drive, Room 7192, MSC 7924, Bethesda, MD
20892. 301–435–0287.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS.)
Dated: January 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–383 Filed 1–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Clinical Trials Subcommittee.
Date: February 9, 2005.
Open: 8 p.m. to 9 p.m.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
1729
Agenda: To discuss clinical trial policy.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Closed: 9 p.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: John Marler, MD,
Associate Director for Clinical Trials,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2216, Bethesda,
MD 20892. (301) 496–9135. jm137f@nih.gov.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Training, Career Development, and Special
Programs Subcommittee.
Date: February 9, 2005.
Open: 8 p.m. to 9:30 p.m.
Agenda: To discuss the training programs
of the Institute.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Closed: 9:30 p.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Margaret Jacobs, Acting
Training and Special Programs Officer,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2154 MSC 9527,
Bethesda, MD 20892–9527. 301–496–4188.
mj22o@nih.gov.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 10–11, 2005.
Open: February 10, 2005, 8:30 a.m. to 3:45
p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Research; Overview of the NINDS
Intramural Program; scientific presentation,
and other administrative and program
developments.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 10, 2005, 3:45 p.m. to
4:45 p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 11, 2005, 8 a.m. to 11:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892. (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
E:\FR\FM\10JAN1.SGM
10JAN1
1730
Federal Register / Vol. 70, No. 6 / Monday, January 10, 2005 / Notices
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: January, 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–384 Filed 1–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Neurological Disorders and Stroke Special
Emphasis Panel, Studies in Autonomic
Disorders.
Date: January 11–12, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, Washington, DC.
Contact Person: Andrea Sawczuk, DDS,
PhD, Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research, NINDS/NIH/DHHS,
6100 Executive Boulevard, Room #3208,
VerDate jul<14>2003
18:09 Jan 07, 2005
Jkt 205001
Bethesda, MD 20892. (301) 496–0660.
sawczuka@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: January 3, 2005.
Laverne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–385 Filed 1–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussion could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, Roadmap Imaging
Probes.
Date: March 15–16, 2005.
Time: 8 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Prabha L. Atreya, PhD.,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging and Bioengineering,
Bethesda, MD 20892. (301) 496–8633.
atreyapr@mail.nih.gov.
Dated: January 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–387 Filed 1–7–05; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel Training Grant
Review.
Date: February 9, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Bonnie Dunn, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging and Bioengineering,
6707 Democracy Blvd., Suite 920, Bethesda,
MD 20892. 301–496–8633.
dunnbo@mail.nih.gov.
Dated: January 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–388 Filed 1–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Bureau of Customs and Border
Protection
Modification of the National Customs
Automation Program Test Regarding
Reconciliation
Customs and Border Protection,
Homeland Security.
ACTION: General notice.
AGENCY:
SUMMARY: This document modifies the
Customs and Border Protection
Automated Commercial System
Reconciliation prototype test by
changing the requirement for filing the
E:\FR\FM\10JAN1.SGM
10JAN1
]]>Agencies
[Federal Register Volume 70, Number 6 (Monday, January 10, 2005)]
[Notices]
[Pages 1729-1730]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-384]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the National
Advisory Neurological Disorders and Stroke Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Clinical Trials Subcommittee.
Date: February 9, 2005.
Open: 8 p.m. to 9 p.m.
Agenda: To discuss clinical trial policy.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Closed: 9 p.m. to 10 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: John Marler, MD, Associate Director for Clinical
Trials, National Institute of Neurological Disorders and Stroke,
National Institutes of Health, 6001 Executive Blvd., Suite 2216,
Bethesda, MD 20892. (301) 496-9135. jm137f@nih.gov.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Training, Career Development, and Special Programs
Subcommittee.
Date: February 9, 2005.
Open: 8 p.m. to 9:30 p.m.
Agenda: To discuss the training programs of the Institute.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Closed: 9:30 p.m. to 10 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Margaret Jacobs, Acting Training and Special
Programs Officer, National Institute of Neurological Disorders and
Stroke, National Institutes of Health, 6001 Executive Blvd., Suite
2154 MSC 9527, Bethesda, MD 20892-9527. 301-496-4188. mj22o@nih.gov.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: February 10-11, 2005.
Open: February 10, 2005, 8:30 a.m. to 3:45 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Research; Overview of the NINDS Intramural
Program; scientific presentation, and other administrative and
program developments.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: February 10, 2005, 3:45 p.m. to 4:45 p.m.
Agenda: To review and evaluate the Division of Intramural
Research Board of Scientific Counselors' reports.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: February 11, 2005, 8 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD, Associate Director for
Extramural Research, National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892. (301) 496-9248.
Any interested person may file written comments with the
committee by forwarding
[[Page 1730]]
the statement to the Contact Person listed on this notice. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign-in at the security desk upon entering the
building.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: January, 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-384 Filed 1-7-05; 8:45 am]
BILLING CODE 4140-01-M
